Suchergebnisse - "Mu, Guangyan"

PubPharm (6)

1

Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects

enthalten in: Clinical drug investigation | 2022

von Xiang, Q. | Liu, Z. | Mu, G. | +10

2

Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients

enthalten in: Cardiovascular drugs and therapy | 2021

von Zhou, S. | Wang, Z. | Liu, Z. | +6

3

Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis

enthalten in: European journal of clinical pharmacology | 2021

von Mu, G. | Zhang, H. | Liu, Z. | +9

4

Target Drug-Calibrated Anti-Xa Activity Assays and Expected Peak–Trough Levels in an Asian Population: A Multicenter Study

enthalten in: American journal of cardiovascular drugs | 2021

von Liu, Z. | Xie, Q. | Zhang, H. | +6

5

Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials

enthalten in: Advances in therapy | 2020

von Mu, G. | Xiang, Q. | Zhou, S. | +9

6

Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer: a systematic review and meta-analysis

enthalten in: Breast cancer research and treatment | 2018

von Zhang, Z. | Li, C. | Fan, H. | +8

1
[1]